Finance

Lists
000105:KRX
Yuhan Corp Preference Shares
â‚©69,900.00
0.00%
(0.00) 1D
Sep 7, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 000105...
Open
â‚©69,900
High
â‚©70,100
Low
â‚©69,200
Mkt. cap
6.02T
Avg. vol.
1.34K
Volume
386.00
Dividend
0.86%
Quarterly dividend
â‚©150
Ex-dividend date
Feb 26, 2026
P/E ratio
21.97
52-wk high
â‚©115,300
52-wk low
â‚©55,100
EPS
â‚©3,181
Shares outstanding
1.15M
No. of employees
2K
Open
â‚©69,900
High
â‚©70,100
Low
â‚©69,200
Mkt. cap
6.02T
Avg. vol.
1.34K
Volume
386.00
Dividend
0.86%
Quarterly dividend
â‚©150
Ex-dividend date
Feb 26, 2026
P/E ratio
21.97
52-wk high
â‚©115,300
52-wk low
â‚©55,100
EPS
â‚©3,181
Shares outstanding
1.15M
No. of employees
2K
Profile
Yuhan Corporation is a South Korean pharmaceutical and chemical company headquartered in Daebang-dong, Dongjak-gu, Seoul. It was established in 1926 by New Il-han and has been listed on the Korea Stock Exchange since 1962. Yuhan is one of the top Korean pharmaceutical companies, along with Celltrion, Samsung Biologics, GC Pharma, and Hanmi Pharmaceutical. Wikipedia
About Yuhan Corp Preference Shares
CEOWook Je Cho
Employees2.09K
Founded1926
Headquarters-
SectorPharmaceutical industry
Websiteyuhan.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
570.01B
546.07B
526.78B
639.45B
Cost of goods sold
401.57B
333.27B
377.63B
411.75B
Cost of revenue
401.57B
333.27B
377.63B
411.75B
Research and development expenses
45.94B
78.04B
47.24B
60.12B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
94.69B
103.16B
88.43B
99.40B
Operating expense
146.43B
185.79B
140.37B
160.70B
Total operating expenses
548.00B
519.05B
518.00B
572.45B
Operating income
22.01B
27.02B
8.78B
67.00B
Other non operating income
-2.09B
-4.58B
231.25M
-6.59B
EBT including unusual items
35.18B
120.91B
28.76B
88.37B
EBT excluding unusual items
34.24B
112.36B
26.45B
84.89B
Income tax expense
14.01B
10.77B
5.39B
20.33B
Effective tax rate
39.83%
8.91%
18.75%
23.00%
Other operating expenses
1.68B
3.00B
1.94B
2.87B
Net income
25.28B
114.43B
27.04B
70.32B
Net profit margin
4.44%
20.96%
5.13%
11.00%
Earnings per share
348.00
1.53K
372.00
950.00
Interest and investment income
2.11B
2.13B
2.35B
2.47B
Interest expense
-3.99B
-3.91B
-3.86B
-3.89B
Net interest expenses
-1.88B
-1.77B
-1.51B
-1.42B
Depreciation and amortization charges
2.12B
962.24M
1.52B
1.48B
EBITDA
40.00B
44.17B
27.88B
90.47B
Gain or loss from assets sale
9.44M
-9.65B
15.64M
291.06M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps